Australia's Cochlear slips; Jarden flags weak demand on Middle East conflict disruptions

Cochlear

22/04/2026 04:49

Updates

** Shares of Cochlear COH.AX fall as much as 41.7% to A$97.88, their weakest intraday trading session

** Stock touches its lowest level since February 11, 2016

** Jarden says the hearing implants maker largely affected by implant segment, Middle East disruptions among others

** Says weak product mix, competition have dragged demand

** Company expects FY26 underlying net profit to be between A$290 million and A$330 million ($236.31 million), sharply lower from its previous forecast of A$435 million to A$460 million

** "This guidance downgrade is far worse than anticipated" - Jarden

** Company warns of risks arising from Middle East conflict, including potential order cancellations

** Expects nearly additional A$25  million after‑tax hit to second-half earnings

** Avg rating from 16 analysts suggest "hold"; their median PT is A$239, LSEG-complied data shows

** Stock down 60.2% YTD, including the day's moves

($1 = 1.3965 Australian dollars)

 (Reporting by Shivangi Lahiri and Aamir Sheik Khalid in Bengaluru)

 ((shivangi.lahiri@thomsonreuters.com))